Cushing’s Syndrome

Definition | Aetiology | Pathophysiology | Risk Factors | Signs and Symptoms | Investigations | Management | Example Management | References

Definition

Cushing’s syndrome is a hormonal disorder caused by prolonged exposure of the body's tissues to high levels of the hormone cortisol. It can be due to endogenous factors such as adrenal tumours or exogenous factors such as long-term use of corticosteroid medications.

Aetiology

Cushing’s syndrome can be caused by a variety of factors:

  • Exogenous: Prolonged use of corticosteroid medications is the most common cause.
  • Endogenous:
    • ACTH-dependent causes, such as pituitary adenomas (Cushing's disease) or ectopic ACTH production by tumours.
    • ACTH-independent causes, such as adrenal adenomas or carcinomas.

Pathophysiology

Cortisol is a glucocorticoid hormone produced by the adrenal glands. It helps regulate metabolism, immune response, and stress. In Cushing’s syndrome, excess cortisol can lead to:

  • Increased gluconeogenesis and insulin resistance, causing hyperglycaemia and diabetes.
  • Protein catabolism, leading to muscle weakness and thinning of the skin.
  • Redistribution of body fat, resulting in central obesity, moon face, and buffalo hump.
  • Suppression of the immune system, increasing susceptibility to infections.
  • Hypertension due to increased mineralocorticoid activity.

Risk Factors

  • Long-term use of corticosteroid medications
  • Adrenal or pituitary tumours
  • Ectopic ACTH-producing tumours
  • Family history of endocrine disorders

Signs and Symptoms

Common signs and symptoms of Cushing’s syndrome include:

  • Weight gain, particularly around the abdomen and face
  • Rounded face (moon face)
  • Fatty hump between the shoulders (buffalo hump)
  • Thinning of the skin, easy bruising
  • Muscle weakness
  • Purple or pink stretch marks (striae) on the skin
  • High blood pressure
  • Osteoporosis
  • Hirsutism (excess hair growth) in women
  • Irregular or absent menstrual periods
  • Mood changes, such as depression, anxiety, and irritability

Investigations

  • Clinical history and physical examination
  • 24-hour urinary free cortisol test: Measures cortisol levels in urine over 24 hours
  • Low-dose dexamethasone suppression test: Assesses cortisol suppression response
  • Midnight serum or salivary cortisol levels: Evaluates cortisol levels at night
  • Imaging studies: CT or MRI of the adrenal glands and pituitary gland to identify tumours or abnormalities
  • Blood tests: To measure ACTH levels and differentiate between ACTH-dependent and ACTH-independent causes

Management

Primary Care Management

  • Referral to endocrinologist: For confirmation of diagnosis and specialised management
  • Monitoring: Regular follow-up to assess symptoms, cortisol levels, and response to treatment
  • Education: Informing patients about the condition, its symptoms, and the importance of medication adherence

Specialist Management

  • Surgical removal of tumours: Adrenalectomy for adrenal tumours or transsphenoidal surgery for pituitary adenomas
  • Radiation therapy: For pituitary tumours that cannot be completely removed by surgery
  • Medications: To control cortisol production (e.g., ketoconazole, metyrapone, mitotane, or mifepristone)
  • Management of complications: Treatment for diabetes, hypertension, osteoporosis, and infections
  • Hormone replacement therapy: For patients who undergo adrenalectomy or pituitary surgery

Example Management for Cushing’s Syndrome

A patient diagnosed with Cushing’s syndrome due to a pituitary adenoma (Cushing's disease) should be referred to an endocrinologist for specialised management. Surgical removal of the tumour (transsphenoidal surgery) is often the first-line treatment. If surgery is not feasible or the tumour cannot be completely removed, radiation therapy or medications to control cortisol production may be used. The patient should be monitored regularly to assess symptoms, cortisol levels, and the response to treatment. Management of complications such as hypertension, diabetes, and osteoporosis is also crucial.

References

  1. NICE. (2024). Cushing’s Syndrome: Diagnosis and Management. Retrieved from NICE
  2. NHS. (2023). Cushing’s Syndrome. Retrieved from NHS
  3. Endocrine Society. (2022). Clinical Practice Guidelines for Cushing’s Syndrome. Retrieved from Endocrine Society
  4. European Society of Endocrinology (ESE). (2021). Management of Cushing’s Syndrome. Retrieved from ESE

Back to Top

 
 
 

Check out our youtube channel

Donate
 

Jump to other topics below: